Arcellx, Inc. (ACLX)
USD 55.64
(-5.03%)
USD 55.64
(-5.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 108.27 Million USD | 4968.66% |
| 2022 | -2.22 Million USD | -113.64% |
| 2021 | -1.04 Million USD | -65.5% |
| 2020 | -629 Thousand USD | -92.94% |
| 2019 | -326 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 38.43 Million USD | -38.44% |
| 2024 Q2 | 26.14 Million USD | -31.97% |
| 2023 Q2 | 13.6 Million USD | -20.77% |
| 2023 Q1 | 17.17 Million USD | 2461.76% |
| 2023 FY | 108.27 Million USD | 4968.66% |
| 2023 Q4 | 62.42 Million USD | 330.23% |
| 2023 Q3 | 14.51 Million USD | 6.66% |
| 2022 Q1 | -323 Thousand USD | 2.42% |
| 2022 FY | -2.22 Million USD | -113.64% |
| 2022 Q4 | -727 Thousand USD | -10.15% |
| 2022 Q3 | -660 Thousand USD | 97.01% |
| 2022 Q2 | -22.08 Million USD | -6736.84% |
| 2021 Q1 | -207 Thousand USD | -25.45% |
| 2021 Q4 | -331 Thousand USD | -30.83% |
| 2021 Q3 | -253 Thousand USD | 0.0% |
| 2021 Q2 | - USD | 100.0% |
| 2021 FY | -1.04 Million USD | -65.5% |
| 2020 FY | -629 Thousand USD | -92.94% |
| 2020 Q4 | -165 Thousand USD | 0.0% |
| 2019 FY | -326 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -184.757% |
| Alkermes plc | 1.37 Billion USD | 92.123% |
| Agenus Inc. | 139.61 Million USD | 22.445% |
| Aptorum Group Limited | -1.11 Million USD | 9813.839% |
| Ardelyx, Inc. | 106.66 Million USD | -1.517% |
| Dyadic International, Inc. | 922.95 Thousand USD | -11631.749% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -414.121% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 62029.274% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 910.602% |
| Novavax, Inc. | 639.93 Million USD | 83.08% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 331.173% |
| Pyxis Oncology, Inc. | -2 Million USD | 5513.95% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 21054.008% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -468.603% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 245141.64% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 20646.3% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 210.245% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -13401.122% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 132147.561% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 19.953% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1275.67% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 211.685% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 92.866% |
| AlloVir, Inc. | -398 Thousand USD | 27305.779% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 55.021% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -25437.5% |
| Bicycle Therapeutics plc | -129.52 Million USD | 183.6% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -90132.5% |
| ChromaDex Corporation | 50.78 Million USD | -113.232% |
| Chimerix, Inc. | 324 Thousand USD | -33319.444% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 447.408% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 239.538% |
| CRISPR Therapeutics AG | 240.95 Million USD | 55.063% |
| Precision BioSciences, Inc. | 40.47 Million USD | -167.541% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 210.305% |
| Fortress Biotech, Inc. | 57.85 Million USD | -87.162% |
| Fortress Biotech, Inc. | 57.85 Million USD | -87.162% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -553.188% |
| ImmuCell Corporation | 4.39 Million USD | -2362.966% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 202.032% |
| Immix Biopharma, Inc. | -5468.00 USD | 1980330.432% |
| Incyte Corporation | 3.44 Billion USD | 96.853% |
| Innoviva, Inc. | 261.06 Million USD | 58.524% |
| IO Biotech, Inc. | -756 Thousand USD | 14422.619% |
| Jaguar Health, Inc. | 7.72 Million USD | -1301.851% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 16407.078% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 9.581% |
| ContextLogic Inc. | 59 Million USD | -83.524% |
| MiMedx Group, Inc. | 266.84 Million USD | 59.422% |
| MEI Pharma, Inc. | 49.32 Million USD | -119.513% |
| NextCure, Inc. | -3.68 Million USD | 3039.169% |
| Onconetix, Inc. | -1.12 Million USD | 9706.313% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 473.788% |
| Opthea Limited | 21.72 Thousand USD | -498422.099% |
| Psyence Biomedical Ltd. | -240.00 USD | 45116350.0% |
| Vaxcyte, Inc. | -75 Million USD | 244.372% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 188982.88% |
| Precigen, Inc. | 106 Thousand USD | -102050.0% |
| Pharming Group N.V. | 220.1 Million USD | 50.806% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -20925.049% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -10631.318% |
| PureTech Health plc | -1.6 Million USD | 6854.772% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 1.36% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 159.688% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 338.895% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 592.468% |
| Acelyrin, Inc. | -115 Thousand USD | 94255.652% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1077395.791% |
| Summit Therapeutics Inc. | -2.05 Million USD | 5381.902% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 19063.047% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4135.744% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2572.896% |
| Elevation Oncology, Inc. | -39 Thousand USD | 277738.462% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2356.753% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2846.77% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -271.722% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -21730.444% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 196970.909% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -4.015% |
| Seer, Inc. | 7.02 Million USD | -1440.899% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2373.253% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -402.571% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 91481.624% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 75660.533% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -17679.803% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 10.123% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 65.48% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2165680.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4106.643% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 213499.685% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -268.459% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 46771.983% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 22107.927% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1625.486% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 22917.436% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1041244.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -111171.079% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1101.749% |
| Kura Oncology, Inc. | -849 Thousand USD | 12853.71% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 261.36% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 73759.184% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -9.33% |
| Autolus Therapeutics plc | -4.86 Million USD | 2324.759% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -161.632% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 64551.786% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -14.311% |
| GRI Bio, Inc. | 10.84 Million USD | -898.792% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4162.976% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1346.449% |
| IGM Biosciences, Inc. | -211.66 Million USD | 151.157% |
| INmune Bio, Inc. | 155 Thousand USD | -69757.419% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -74.816% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7288.452% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16798.023% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 369981.123% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -26835.075% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 5524.8% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 34693.93% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -14.628% |
| Verastem, Inc. | -62 Thousand USD | 174743.548% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -4346.776% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 41586.207% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3477.106% |
| Histogen Inc. | 3.76 Million USD | -2772.884% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -18692.597% |
| Surrozen, Inc. | -27.23 Million USD | 497.646% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2109.26% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 9086.704% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 522.19% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -439.991% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 5468736.364% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1684.89% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 161395.08% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 30.048% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -74165.432% |
| Apollomics, Inc. | 127 Thousand USD | -85159.055% |
| Amarin Corporation plc | 165.54 Million USD | 34.591% |
| Mesoblast Limited | -9.81 Million USD | 1203.199% |
| Turnstone Biologics Corp. | 16.5 Million USD | -555.998% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 198.0% |
| Synaptogenix, Inc. | -6347.00 USD | 1706087.081% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 212411.765% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 32.898% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 93.84% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4067.717% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 196.539% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 67.972% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 949249.719% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1829.696% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9872.473% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1379.625% |
| Insmed Incorporated | 239.63 Million USD | 54.815% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2926.244% |
| OmniAb, Inc. | 14.66 Million USD | -638.249% |
| Alector, Inc. | -95.05 Million USD | 213.914% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 13.805% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 349.129% |
| Zai Lab Limited | 170.9 Million USD | 36.643% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -32.246% |
| Aura Biosciences, Inc. | -1.29 Million USD | 8461.313% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -83191.538% |
| Immunic, Inc. | -111 Thousand USD | 97648.649% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -582.976% |
| Veracyte, Inc. | 248.14 Million USD | 56.365% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.549% |
| FibroGen, Inc. | 128.9 Million USD | 16.0% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 19198504.255% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1028.088% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.814% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -27735.219% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 69.528% |
| TG Therapeutics, Inc. | 219.1 Million USD | 50.582% |
| Galecto, Inc. | -830 Thousand USD | 13145.663% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 7917.978% |
| Fortrea Holdings Inc. | 424 Million USD | 74.463% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 225.662% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 19196.825% |
| XBiotech Inc. | -1.74 Million USD | 6308.658% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9872.473% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 333.003% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 243.351% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -47.513% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -544.403% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 72.168% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 318.098% |
| Vaxxinity, Inc. | -2.23 Million USD | 4946.867% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 66.862% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1056.204% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -342.841% |
| NexImmune, Inc. | -1.02 Million USD | 10664.093% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2005066.667% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1623.842% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.042% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 162128.821% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3149.254% |
| Ainos, Inc. | -253.73 Thousand USD | 42774.386% |
| Pluri Inc. | 322 Thousand USD | -33527.019% |
| Prothena Corporation plc | -129.2 Million USD | 183.807% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -114.737% |
| Celularity Inc. | 6.75 Million USD | -1502.946% |
| Rallybio Corporation | -150 Thousand USD | 72286.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 432.073% |
| MeiraGTx Holdings plc | 287 Thousand USD | -37627.875% |
| Omeros Corporation | -69.77 Million USD | 255.174% |
| Humacyte, Inc. | -76.55 Million USD | 241.449% |
| Immunocore Holdings plc | 248.39 Million USD | 56.408% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 813.818% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -73.574% |
| Blueprint Medicines Corporation | 236.58 Million USD | 54.232% |
| CalciMedica, Inc. | -58 Thousand USD | 186787.931% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 7693.198% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -272.669% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3907.278% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 450.815% |
| Pulmatrix, Inc. | -8.22 Million USD | 1417.263% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 9354.615% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 27237.594% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 127.152% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3801.124% |
| Cytokinetics, Incorporated | -322.59 Million USD | 133.565% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12459.839% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 31853.372% |
| Vor Biopharma Inc. | -3.49 Million USD | 3200.773% |
| Roivant Sciences Ltd. | 109.23 Million USD | 0.875% |
| Evogene Ltd. | 1.39 Million USD | -7639.743% |
| ProKidney Corp. | -3.16 Million USD | 3516.819% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 346.582% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1479.102% |
| CorMedix Inc. | -205.56 Thousand USD | 52774.619% |
| BioLineRx Ltd. | 1.1 Million USD | -9672.473% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 237.635% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 328218.182% |
| Atai Life Sciences N.V. | -5000.00 USD | 2165680.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 88955.973% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 112890.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 7895.464% |
| Sagimet Biosciences Inc. | 2 Million USD | -5313.95% |
| MediciNova, Inc. | 979.7 Thousand USD | -10952.204% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 228.416% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 114614.304% |
| GeoVax Labs, Inc. | -20.72 Million USD | 622.563% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 55.72% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2677.458% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 87.587% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1358.107% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 35028.71% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 902425.0% |
| Absci Corporation | -41.84 Million USD | 358.737% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2165680.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 241.777% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4499.797% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 49.34% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 11606.801% |
| Allakos Inc. | -6.14 Million USD | 1863.214% |
| Imunon, Inc. | -720 Thousand USD | 15138.646% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 256.935% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 77.247% |
| BioAtla, Inc. | -103.73 Million USD | 204.384% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 949249.719% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 60930.899% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 144.592% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 34916.399% |
| XOMA Corporation | 3.86 Million USD | -2704.429% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 254.497% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -631.912% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4634.296% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -769.013% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 373475.862% |
| Viridian Therapeutics, Inc. | -1 Million USD | 10841.964% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -832915284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 2707075.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 82.999% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -55510.966% |
| UroGen Pharma Ltd. | 73.35 Million USD | -47.616% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 505.63% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -932535.659% |
| Orgenesis Inc. | -5.72 Million USD | 1991.336% |
| Entera Bio Ltd. | -56 Thousand USD | 193455.357% |
| GH Research PLC | -315 Thousand USD | 34474.286% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 57390.476% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 20724.571% |
| Xencor, Inc. | -85.26 Million USD | 226.999% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 49100.122% |
| Replimune Group, Inc. | -2.65 Million USD | 4178.305% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 10914.533% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 39.116% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -55510.966% |
| Portage Biotech Inc. | -54 Thousand USD | 200616.667% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 114614.304% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 28821.22% |
| OncoCyte Corporation | 413 Thousand USD | -26117.676% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2408976.529% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 48774424.324% |
| Purple Biotech Ltd. | -196 Thousand USD | 55344.388% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1107.393% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1006.921% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1136.663% |
| HilleVax, Inc. | -2.15 Million USD | 5122.217% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 111727.835% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 721767.555% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 16309.431% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 470878.261% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1442635.198% |
| Savara Inc. | -44.26 Million USD | 344.632% |
| Curis, Inc. | 9.81 Million USD | -1003.649% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3809.664% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 86870.363% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 6362.522% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 47590.789% |
| BeiGene, Ltd. | 2.07 Billion USD | 94.791% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3972.778% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 127.093% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -91.009% |
| Erasca, Inc. | -3.73 Million USD | 3001.367% |
| bluebird bio, Inc. | -4.03 Million USD | 2786.824% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 383823.155% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.314% |
| DBV Technologies S.A. | 15.72 Million USD | -588.447% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 383823.155% |
| Moderna, Inc. | 2.15 Billion USD | 94.975% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 11933.77% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1252.473% |
| Molecular Templates, Inc. | 50.39 Million USD | -114.861% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 20301.306% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 19.067% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1840.26% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 375.218% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 197.436% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3117.809% |
| MacroGenics, Inc. | 50.52 Million USD | -114.299% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1875.648% |
| Prime Medicine, Inc. | -147.9 Million USD | 173.208% |
| Aditxt, Inc. | -111.66 Thousand USD | 97072.058% |
| Adagene Inc. | 18.11 Million USD | -497.847% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -22088.32% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 22.769% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 31.398% |
| SciSparc Ltd. | 2.19 Million USD | -4830.738% |
| Vericel Corporation | 135.57 Million USD | 20.134% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 432368.753% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 349590.026% |
| Generation Bio Co. | -73.91 Million USD | 246.499% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 24877.803% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -98.244% |
| Invivyd, Inc. | -2.02 Million USD | 5439.201% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 135.992% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 104780.098% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -12.36% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -10.165% |
| ADMA Biologics, Inc. | 88.21 Million USD | -22.74% |
| Clene Inc. | 533 Thousand USD | -20215.009% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -349.119% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 11414.42% |
| GeoVax Labs, Inc. | -20.72 Million USD | 622.563% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -5346.63% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 55823.152% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -117.406% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1626.777% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 13052.033% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -29.808% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -148000.175% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -103.677% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 162.521% |
| Trevena, Inc. | 1.45 Million USD | -7341.856% |
| Surrozen, Inc. | -27.23 Million USD | 497.646% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 30773.938% |
| Cingulate Inc. | -582.91 Thousand USD | 18675.34% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 349387.097% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 649.667% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1430469.881% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 12390.465% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 84.093% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 11059.413% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 192281.676% |
| Kronos Bio, Inc. | 1.37 Million USD | -7792.055% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 301.765% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 37181.849% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 22274.052% |
| ImmunityBio, Inc. | -17.89 Million USD | 705.249% |
| Korro Bio, Inc. | -3.63 Million USD | 3082.893% |
| Kineta, Inc. | 5.43 Million USD | -1892.987% |
| BioVie Inc. | -229.37 Thousand USD | 47305.692% |
| Codexis, Inc. | 57.33 Million USD | -88.857% |
| Celularity Inc. | 6.75 Million USD | -1502.946% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2598.206% |
| Celcuity Inc. | -142.77 Thousand USD | 75940.501% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -213932.417% |
| Cibus, Inc. | 1.42 Million USD | -7514.557% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 29051.604% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 572.442% |
| IN8bio, Inc. | -2.5 Million USD | 4429.428% |
| Kodiak Sciences Inc. | -25.94 Million USD | 517.308% |
| Annexon, Inc. | -3.26 Million USD | 3414.325% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 5397.407% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 359.432% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -16818.594% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 86.092% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 37.395% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5798.895% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 434.515% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -36.709% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 611.909% |
| Moolec Science SA | -143.3 Thousand USD | 75658.424% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 355.87% |
| Geron Corporation | -123.5 Million USD | 187.673% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3194.159% |
| Royalty Pharma plc | 1.79 Billion USD | 93.964% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 254.486% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2997857.475% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -46694.819% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 197.186% |
| Humacyte, Inc. | -76.55 Million USD | 241.449% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 11507.708% |
| 89bio, Inc. | -273 Thousand USD | 39762.637% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 8714.081% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 12868.75% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 88131.707% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -9576.408% |
| Notable Labs, Ltd. | 113 Thousand USD | -95722.124% |
| Liquidia Corporation | 14.6 Million USD | -641.637% |
| Mustang Bio, Inc. | -2.22 Million USD | 4966.472% |
| Immunovant, Inc. | -231 Thousand USD | 46974.026% |
| Quantum-Si incorporated | 488 Thousand USD | -22088.32% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 294.89% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 361030.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5715.199% |
| Acasti Pharma Inc. | -11 Thousand USD | 984454.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 53017.89% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16798.023% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 164.64% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -9443.532% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 28519.685% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5630.082% |
| PepGen Inc. | -1.18 Million USD | 9245.186% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 85359.055% |
| United Therapeutics Corporation | 2.07 Billion USD | 94.769% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 572.896% |
| Solid Biosciences Inc. | -76.56 Million USD | 241.425% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 131215.363% |
| Immuneering Corporation | -764.13 Thousand USD | 14270.084% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -163305.469% |
| Belite Bio, Inc | -399 Thousand USD | 27237.594% |
| XOMA Corporation | 3.86 Million USD | -2704.429% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 640.422% |
| Bionomics Limited | -434.44 Thousand USD | 25023.294% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10181.844% |
| uniQure N.V. | 2.21 Million USD | -4788.442% |
| Cassava Sciences, Inc. | -89.42 Million USD | 221.086% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 217.606% |
| Forte Biosciences, Inc. | -9000.00 USD | 1203200.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 13067.545% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 24877.803% |
| Altimmune, Inc. | -65.37 Million USD | 265.633% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 70.091% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10181.844% |
| Compugen Ltd. | 31.45 Million USD | -244.235% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29342.123% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -341.667% |
| Benitec Biopharma Inc. | 108 Thousand USD | -100158.333% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 138919.231% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 9100.748% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 6042.865% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 91090.756% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 9100.748% |
| Instil Bio, Inc. | -4.75 Million USD | 2376.682% |
| argenx SE | 1.1 Billion USD | 90.232% |
| Immunome, Inc. | -8.9 Million USD | 1315.662% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5829.048% |
| Verona Pharma plc | -679.62 Thousand USD | 16032.192% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 61973.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4640.0% |
| CervoMed Inc. | -1.29 Million USD | 8470.187% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4598.504% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2366.674% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4281.991% |
| Moolec Science SA | -143.3 Thousand USD | 75658.424% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 26637.019% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4153.074% |
| AnaptysBio, Inc. | 14.78 Million USD | -632.555% |
| Design Therapeutics, Inc. | -537 Thousand USD | 20263.687% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 25458.08% |
| NeurAxis, Inc. | 2.15 Million USD | -4920.578% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4945.62% |
| Lumos Pharma, Inc. | 2 Million USD | -5295.067% |
| Achilles Therapeutics plc | -4.73 Million USD | 2388.584% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 61973.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 102564.159% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -242.019% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12459.839% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 10592.151% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 337.725% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -251711.628% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 13272.628% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 823013.817% |
| Palisade Bio, Inc. | 246 Thousand USD | -43915.854% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 328218.182% |
| Beam Therapeutics Inc. | -59.67 Million USD | 281.457% |
| Neurogene Inc. | -3.26 Million USD | 3419.405% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 22.289% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3032.801% |
| Sesen Bio, Inc. | 40 Million USD | -170.698% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 36557.576% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2788.801% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1231.915% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -669.027% |
| Athira Pharma, Inc. | -969 Thousand USD | 11274.303% |
| Vaccinex, Inc. | -16 Million USD | 776.575% |
| HCW Biologics Inc. | -574.82 Thousand USD | 18936.896% |
| XOMA Corporation | 3.86 Million USD | -2704.429% |
| Nektar Therapeutics | 53.47 Million USD | -102.474% |
| Arvinas, Inc. | 71.8 Million USD | -50.806% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 229.736% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 272.487% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 33727.019% |
| Rezolute, Inc. | -36 Thousand USD | 300875.0% |
| Clene Inc. | 533 Thousand USD | -20215.009% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 8433043.925% |
| BeyondSpring Inc. | 1.75 Million USD | -6083.838% |
| Synlogic, Inc. | -1.92 Million USD | 5727.807% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 292745.946% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1810.028% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29342.123% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 671.001% |
| Krystal Biotech, Inc. | 47.6 Million USD | -127.453% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 23.256% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2054.806% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4281.917% |
| MannKind Corporation | 136.19 Million USD | 20.495% |
| Ikena Oncology, Inc. | -50.49 Million USD | 314.448% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 0.492% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2569.304% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 43067.857% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2165680.0% |
| Legend Biotech Corporation | 140.92 Million USD | 23.168% |
| Mural Oncology plc | -2.56 Million USD | 4318.115% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 19751.361% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 108379.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -421.726% |
| REGENXBIO Inc. | 53.02 Million USD | -104.188% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2121.28% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 56385.38% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 6351.674% |
| Vaxart, Inc. | -60.76 Million USD | 278.199% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 41305.191% |
| Cellectis S.A. | 18 Thousand USD | -601450.0% |
| Longeveron Inc. | 221 Thousand USD | -48895.023% |
| Repare Therapeutics Inc. | -80.07 Million USD | 235.23% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 90.093% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 8467.774% |
| Revolution Medicines, Inc. | -399.66 Million USD | 127.093% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 309468.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -220877.551% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.742% |
| Denali Therapeutics Inc. | -93.34 Million USD | 215.999% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 432368.753% |
| Veru Inc. | 7.56 Million USD | -1331.14% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 71807.947% |
| Cingulate Inc. | -582.91 Thousand USD | 18675.34% |
| Passage Bio, Inc. | -3.72 Million USD | 3009.944% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 899128.562% |
| Exicure, Inc. | -1.42 Million USD | 7709.206% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 28371.279% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3905.882% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 21220.398% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -58.939% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 72475.624% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 282.885% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -27592.839% |
| OmniAb, Inc. | 14.66 Million USD | -638.249% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -441.585% |
| Lipocine Inc. | -2.85 Million USD | 3898.173% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 5975.149% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1997.967% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7288.452% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -43.766% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 166683.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -28.451% |
| Ocugen, Inc. | -33.53 Million USD | 422.864% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3524.383% |
| Q32 Bio Inc. | 578 Thousand USD | -18633.391% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 40960.0% |
| Alumis Inc. Common Stock | -1.28 Million USD | 8532.944% |
| Equillium, Inc. | 35.95 Million USD | -201.126% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 6443.234% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -21526.431% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2619330.769% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 41906.564% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -25515.313% |
| Dominari Holdings Inc. | 2.03 Million USD | -5210.397% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 59116.956% |
| vTv Therapeutics Inc. | -13.59 Million USD | 896.462% |
| Bio-Techne Corporation | 773.07 Million USD | 85.994% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -525.204% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 76.501% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 9362.532% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 551.539% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -825.699% |
| Nkarta, Inc. | -5.86 Million USD | 1944.931% |
| BioCardia, Inc. | -7.24 Million USD | 1593.709% |
| Iterum Therapeutics plc | -1.75 Million USD | 6287.371% |